SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-012283
Filing Date
2003-07-01
Accepted
2003-07-01 14:06:20
Documents
1
Period of Report
2003-06-27

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP rrd12339.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP rrd12339.xml 4 7953
  Complete submission text file 0001181431-03-012283.txt   9793
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Issuer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 100 BEAVER STREET WALTHAM MA 02453 7813982311
HENNESSEY ROBERT J (Reporting) CIK: 0001234374 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10824 | Film No.: 03767458